title: ADRA2A is involved in neuro-endocrine regulation of bone resorption.
abstract: Adrenergic stimulation is important for osteoclast differentiation and bone resorption. Previous research shows that this happens through β2-adrenergic receptor (AR), but there are conflicting evidence on presence and role of α2A-AR in bone. The aim of this study was to investigate the presence of α2A-AR and its involvement in neuro-endocrine signalling of bone remodelling in humans. Real-time polymerase chain reaction (PCR) and immunohistochemistry were used to investigate α2A-AR receptor presence and localization in bone cells. Functionality of rs553668 and rs1800544 single nucleotide polymorphism SNPs located in α2A-AR gene was analysed by qPCR expression on bone samples and luciferase reporter assay in human osteosarcoma HOS cells. Using real-time PCR, genetic association study between rs553668 A>G and rs1800544 C>G SNPs and major bone markers was performed on 661 Slovenian patients with osteoporosis. α2A-AR is expressed in osteoblasts and lining cells but not in osteocytes. SNP rs553668 has a significant influence on α2A-AR mRNA level in human bone samples through the stability of mRNA. α2A-AR gene locus associates with important bone remodelling markers (BMD, CTX, Cathepsin K and pOC). The results of this study are providing comprehensive new evidence that α2A-AR is involved in neuro-endocrine signalling of bone turnover and development of osteoporosis. As shown by our results the neurological signalling is mediated through osteoblasts and result in bone resorption. Genetic study showed association of SNPs in α2A-AR gene locus with bone remodelling markers, identifying the individuals with higher risk of development of osteoporosis.
authors.affiliation: Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
authors.forename: Vid
authors.initials: V
authors.lastname: Mlakar
authors.affiliation: Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
authors.forename: Simona
authors.initials: S
authors.lastname: Jurkovic Mlakar
authors.affiliation: Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
authors.forename: Janja
authors.initials: J
authors.lastname: Zupan
authors.affiliation: Department for Research and Education, General and Teaching Hospital Celje, Celje, Slovenia.
authors.forename: Radko
authors.initials: R
authors.lastname: Komadina
authors.affiliation: Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
authors.forename: Janez
authors.initials: J
authors.lastname: Prezelj
authors.affiliation: Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
authors.forename: Janja
authors.initials: J
authors.lastname: Marc
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D016723:Bone Remodeling; D001862:Bone Resorption / Q000235:genetics / Q000473:pathology* / Q000503:physiopathology; D001842:Bone and Bones / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D019295:Computational Biology; D057075:Enzyme Assays; D005786:Gene Expression Regulation; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D007150:Immunohistochemistry; D008156:Luciferases / Q000378:metabolism; D009490:Neurosecretory Systems / Q000378:metabolism* / Q000473:pathology; D010003:Osteoarthritis / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D010024:Osteoporosis / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D018341:Receptors, Adrenergic, alpha-2 / Q000235:genetics / Q000378:metabolism*
chemical_list: D015415:Biomarkers; D018341:Receptors, Adrenergic, alpha-2; D008156:Luciferases
keywords: ADRA2A; adrenergic signalling; bone; osteoblast; osteoporosis; resorption
references.citation: Cell Tissue Res. 2006 Nov;326(2):541-51
references.pmid: 16896948
references.citation: Int J Obes Relat Metab Disord. 2001 Nov;25(11):1604-8
references.pmid: 11753578
references.citation: Hypertension. 2007 Jan;49(1):96-106
references.pmid: 17159089
references.citation: J Appl Physiol (1985). 2007 Apr;102(4):1502-9
references.pmid: 17185495
references.citation: Metabolism. 2007 Jun;56(6):757-65
references.pmid: 17512307
references.citation: Microsc Res Tech. 2002 Jul 15;58(2):77-84
references.pmid: 12203706
references.citation: Cell. 2002 Nov 1;111(3):305-17
references.pmid: 12419242
references.citation: Nature. 2003 May 15;423(6937):349-55
references.pmid: 12748654
references.citation: Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
references.pmid: 12824337
references.citation: J Appl Physiol (1985). 2004 Jun;96(6):2231-9
references.pmid: 14742450
references.citation: J Bone Joint Surg Am. 1969 Jun;51(4):737-55
references.pmid: 5783851
references.citation: Am J Hypertens. 1995 Sep;8(9):863-9
references.pmid: 8541000
references.citation: Cell. 2005 Jan 14;120(1):15-20
references.pmid: 15652477
references.citation: Nature. 2005 Mar 24;434(7032):514-20
references.pmid: 15724149
references.citation: Expert Opin Ther Targets. 2005 Oct;9(5):931-40
references.pmid: 16185149
references.citation: Bone. 2005 Nov;37(5):622-33
references.pmid: 16157516
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5472-7
references.pmid: 16567612
references.citation: Genes Dev. 2006 Sep 15;20(18):2492-506
references.pmid: 16980579
references.citation: Biochem Biophys Res Commun. 2006 Sep 8;347(4):1001-5
references.pmid: 16854373
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5;141B(4):394-7
references.pmid: 16583406
references.citation: Mol Psychiatry. 2007 Jun;12(6):520-1
references.pmid: 17522710
references.citation: J Bone Miner Metab. 2007;25(4):219-25
references.pmid: 17593491
references.citation: J Neural Transm (Vienna). 2007;114(11):1503-6
references.pmid: 17612790
references.citation: Nucleic Acids Res. 2008 Jan;36(Database issue):D154-8
references.pmid: 17991681
references.citation: BMC Pharmacol. 2007;7:16
references.pmid: 18096057
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2008 Jun 5;147B(4):418-23
references.pmid: 17894416
references.citation: Expert Opin Investig Drugs. 2008 Sep;17(9):1281-99
references.pmid: 18694363
references.citation: Br J Haematol. 2009 Jun;146(1):95-103
references.pmid: 19388931
references.citation: Behav Res Methods. 2009 Nov;41(4):1149-60
references.pmid: 19897823
references.citation: Science. 2010 Jan 8;327(5962):217-20
references.pmid: 19965390
references.citation: Bone. 2010 Jan;46(1):72-80
references.pmid: 19781675
references.citation: J Bone Miner Res. 2011 Mar;26(3):591-603
references.pmid: 20814988
references.citation: J Biomed Sci. 2012;19:28
references.pmid: 22380539
references.citation: Nat Genet. 2012 May;44(5):491-501
references.pmid: 22504420
references.citation: J Biol Chem. 2013 Oct 4;288(40):29193-205
references.pmid: 23965992
references.citation: Cell. 2000 Jan 21;100(2):197-207
references.pmid: 10660043
references.citation: Med Sci Sports Exerc. 2000 Oct;32(10):1709-12
references.pmid: 11039642
references.citation: Biochem Pharmacol. 2001 Mar 1;61(5):579-86
references.pmid: 11239501
references.citation: Biol Psychiatry. 2006 Nov 15;60(10):1028-33
references.pmid: 16806103